Stay updated on Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-15T20:43:57.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer’s revision number changed from v3.7.0 to v3.7.1; the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-08T21:52:41.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study record content and attached documents with a standard error layout. The header includes a Home link, signaling restricted access to the study details.
    Difference
    19%
    Check dated 2026-09-24T21:33:50.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.6 to v3.7.0, indicating a small update to the site's underlying revision metadata. No visible content or functionality is affected.
    Difference
    0.0%
    Check dated 2026-09-17T20:46:23.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, signaling a new version of the page. This appears to be an administrative update rather than a change to the study details or other visible content.
    Difference
    0.0%
    Check dated 2026-09-03T18:45:33.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    A line appears in the study's identifiers section noting 2015 ( U.S. NIH Grant/Contract ), indicating NIH funding as part of the study's background. It places funding attribution alongside other study identifiers.
    Difference
    0.0%
    Check dated 2026-08-27T17:19:09.000Z thumbnail image

Stay in the know with updates to Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alpelisib Plus Fulvestrant in Advanced Breast Cancer Clinical Trial page.